🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to evaluate the efficacy and safety of first-line tr...
Status
Completed
Location
Gemeinschaftspraxis für Hämatologie und Onkologie
Start Date
2018-05-24
Trial ID
NCT03462251
Given the uncertain benefit in efficacy of adding CDK 4/6 to first rather t...
Status
Active Not Recruiting
Location
Jeroen Bosch Ziekenhuis
Start Date
2017-11-09
Trial ID
NCT03425838
Treatments Being Tested
The primary objective of Phase 1b will be to evaluate the safety and tolera...
Status
Terminated
Location
Holy Cross Health Fort Lauderdale - Holy Cross Hospital
Start Date
2023-01-09
Trial ID
NCT05384119
Treatments Being Tested
This phase II trial studies how well letrozole, anastrozole, or fulvestrant...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2019-05-31
Trial ID
NCT04256941
Treatments Being Tested
This multicenter, prospective phase II clinical trial evaluates the efficac...
Status
Recruiting
Location
Sun Yat-sen Memorial Hospital
Start Date
2025-08-18
Trial ID
NCT07037199
Treatments Being Tested
Study STX-478-101 (LY4064809) is a multipart, open-label, phase 1/2 study e...
Status
Recruiting
Location
Ellison Clinic at Saint John's
Start Date
2023-04-17
Trial ID
NCT05768139
A assessment of the efficacy of first-/second-line endocrine therapies ± ta...
Status
Unknown
Location
N.N. Blokhin National Medical Research Center of Oncology
Start Date
2021-01-01
Trial ID
NCT04852081
Treatments Being Tested
To characterize the safety and tolerability, identify recommended doses and...
Status
Terminated
Location
Massachusetts General Hospital Massachusetts General Hospital
Start Date
2016-06-14
Trial ID
NCT02734615
To explore the efficacy and safety of T-DM1 combined with CDK4/6 inhibitor ...
Status
Enrolling By Invitation
Location
Zhejiang Cancer Hospital
Start Date
2023-10-25
Trial ID
NCT06481956
Treatments Being Tested
This study, the first clinical trial of AVZO-021, aims to determine the saf...
Status
Recruiting
Location
Yale Cancer Center
Start Date
2023-08-30
Trial ID
NCT05867251